Medibank share price lifts despite shareholder class action

The health insurer has been hit with another class action relating to its 2022 cyber-attack.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • The Medibank share price is gaining 0.76% to trade at $3.295 right now
  • That's despite news the company is facing a shareholder class action
  • The action alleges Medibank breached continuous disclosure obligations and ASX listing rules 

The Medibank Private Ltd (ASX: MPL) share price is in the green on Thursday despite the company facing a shareholder class action.

It comes on the back of a massive cyber-attack that saw the data of 9.7 million Australians in the hands of hackers late last year.

Right now, the Medicare share price is $3.295, 0.76% higher than its previous close.

For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 0.97% at the time of writing.

Let's take a closer look at the latest news from the ASX 200 health insurance giant.

a woman in a business suit stands with her arms folded in the background of a statue of lady justice wearing robes, carrying a sword and holding the scales of justice.

Image source: Getty Images

Medibank faces shareholder class action

The Medibank share price appears not to have been impacted by news a shareholder class action against the company has been filed in the Supreme Court of Victoria.

The action alleges the company breached continuous disclosure obligations and ASX listing rules by not disclosing information related to alleged deficiencies in its cyber security systems.

Medibank intends to defend the action, understood to have been brought on behalf of investors who bought shares in Medibank between July 2019 and October 2022.

The law firm behind the legal action is United States-based Quinn Emanuel.

Medibank revealed it had been served with the action after the market closed on Wednesday.

The ASX 200 company bore $26.2 million of costs related to the cyber-attack last half.

It expects to fork out another $13.8 million to $18.8 million this half. That's before any potential remediation, regulatory, or litigation costs.

The shareholder class action is the second suit faced by the company as a result of the breach.

Medicare vowed to defend itself against a class action brought on behalf of current and former customers last month. It included allegations of breach of contract, contraventions of Australian consumer law, and breach of equitable obligations of confidence.

It was filed in the Federal Court of Australia and brought by law firm Baker McKenzie, funded by Omni Bridgeway.

Medibank share price snapshot

The Medibank share price tumbled 18% when the company revealed the cyber-attack in October, and it hasn't quite recovered yet. It remains 6% lower than it was prior to its ill-fated announcement.

Though, it has gained 6% over the last 12 months and 13% so far this year.

Comparatively, the ASX 200 has gained 3% year to date and has fallen 5% since this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A doctor and an elderly couple sit at a desk and look at a lung scan uploaded using Alcidion software as the Alcidion share price falls
Healthcare Shares

Why did 4DMedical shares charge higher today, then drop?

The company's key technology has received a bit tick.

Read more »

Business woman working from home with stock market chart showing percent change on her laptop screen.
Healthcare Shares

Should I invest $10,000 in CSL shares before the end of May?

This ASX healthcare giant has fallen hard, but the lower price and improving dividend appeal make it worth another look.

Read more »

A woman wakes up after sleeping soundly, stretching her arms high sitting in bed.
Healthcare Shares

Why this fallen ASX 200 blue chip could be a strong buy

I think the market may be underestimating the durability of this healthcare business.

Read more »

Female pharmacist smiles with a digital tablet.
Broker Notes

3 reasons to buy Sigma Healthcare shares today

A leading analyst expects “impressive growth” from Sigma Healthcare shares.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news.
Healthcare Shares

Could this fallen ASX 200 stock be a once-in-a-decade opportunity?

The valuation now looks far more interesting for a healthcare stock with a global leadership position.

Read more »

Hand dropping a mic.
Healthcare Shares

Pro Medicus shares jump as massive US contract win turns heads

Pro Medicus shares are rocketing after a major US win.

Read more »

Two business people shaking hands in an office
Healthcare Shares

Pro Medicus inks $90m contract

Pro Medicus signs a major $90m contract with Beth Israel Lahey Health, boosting its North American growth outlook.

Read more »

Shattered investor with head in hands, with ASX chart in the background.
Healthcare Shares

CSL shares crash, but is a comeback looming?

Has the market become too pessimistic about Australia's biotech giant?

Read more »